Lorraine Colón-Cartagena
she/her/hers
Assistant Professor of PathologyDownloadHi-Res Photo
Cards
Appointments
Pathology
Primary
Contact Info
About
Titles
Assistant Professor of Pathology
Biography
Dr. Colón-Cartagena completed her residency training in Anatomic and Clinical Pathology at Virginia Commonwealth University. She also completed Fellowship training in Oncologic and Breast Pathology at Memorial Sloan Kettering Cancer Center. She is interested in further understanding the behavior and histologic features of tumors of the breast.
Appointments
Pathology
Assistant ProfessorPrimary
Other Departments & Organizations
Education & Training
- Breast Pathology
- Memorial Sloan Kettering Cancer Center (2023)
- Oncologic Surgical Pathology
- Memorial Sloan Kettering Cancer Center (2022)
- Anatomic and Clinical Pathology
- Virginia Commonwealth University
Research
Research at a Glance
Publications Timeline
A big-picture view of Lorraine Colón-Cartagena's research output by year.
6Publications
13Citations
Publications
2024
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations.
Dopeso H, Gazzo AM, Derakhshan F, Brown DN, Selenica P, Jalali S, Da Cruz Paula A, Marra A, da Silva EM, Basili T, Gusain L, Colon-Cartagena L, Bhaloo SI, Green H, Vanderbilt C, Oesterreich S, Grabenstetter A, Kuba MG, Ross D, Giri D, Wen HY, Zhang H, Brogi E, Weigelt B, Pareja F, Reis-Filho JS. Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations. NPJ Precis Oncol 2024, 8: 33. PMID: 38347189, DOI: 10.1038/s41698-024-00508-x.Peer-Reviewed Original Research
2021
Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization.
Cartagena LC, McGuire K, Zot P, Pillappa R, Idowu M, Robila V. Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization. Clin Breast Cancer 2021, 21: e594-e601. PMID: 33814286, DOI: 10.1016/j.clbc.2021.03.003.Peer-Reviewed Original ResearchPharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β
Pradhan A, Maji S, Bhoopathi P, Talukdar S, Mannangatti P, Guo C, Wang X, Cartagena L, Idowu M, Landry J, Sarkar D, Emdad L, Cavenee W, Das S, Fisher P. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Proceedings Of The National Academy Of Sciences Of The United States Of America 2021, 118: e2103180118. PMID: 34016751, PMCID: PMC8166168, DOI: 10.1073/pnas.2103180118.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAnimalsAntineoplastic AgentsBreast NeoplasmsCell Line, TumorChemokine CCL11Chemokine CCL17FemaleGene Expression Regulation, NeoplasticHumansInterleukin-10Interleukin-1alphaInterleukin-1betaInterleukin-23 Subunit p19Interleukin-5Lung NeoplasmsMiceMice, Inbred BALB COxadiazolesPyrimidinesSignal TransductionSynteninsT-Lymphocytes, CytotoxicTumor BurdenXenograft Model Antitumor AssaysConceptsMDA-9/SynteninMyeloid-derived suppressor cell differentiationSuppressor cell differentiationCancer cellsAdvanced disease stageAggressive breast cancerCytotoxic T lymphocytesMetastatic nodule formationBreast cancer metastasisBreast cancer pathogenesisMda-9/syntenin expressionCancer cell metastasisDirect therapeutic targetsCancer cell linesDiverse cancer cell linesPatient survivalDisease stageIL-1βSyndecan binding proteinBreast cancerInvasive cancer cellsT lymphocytesTherapeutic targetSmall molecule inhibitorsAdvanced stageFalse-Positive (99m)Technetium-Pyrophosphate Scintigraphy in Two Patients With Hypertrophic Cardiomyopathy.
Schafer EB, Tushak Z, Trankle CR, Rao K, Cartagena LC, Shah KB. False-Positive (99m)Technetium-Pyrophosphate Scintigraphy in Two Patients With Hypertrophic Cardiomyopathy. Circ Heart Fail 2021, 14: e007558. PMID: 33663232, DOI: 10.1161/CIRCHEARTFAILURE.120.007558.Peer-Reviewed Original Research
2020
SOX10-positive perivascular cells in sentinel lymph nodes: A reliably intrinsic internal control.
Colon Cartagena L, Wang GY, Idowu MO, Smith SC, Mochel MC. SOX10-positive perivascular cells in sentinel lymph nodes: A reliably intrinsic internal control. J Cutan Pathol 2020, 47: 415-417. PMID: 31894865, DOI: 10.1111/cup.13643.Peer-Reviewed Original Research
2019
Intraductal carcinoma of the prostate
Colon Cartagena L, Zot P, Smith SC. (2019). Intraductal carcinoma of the prostate. ASCP Case Rep Surg Pathol.Commentaries, Editorials and Letters
News
Get In Touch
Contacts
Email